Go Capital is a French venture capital firm investing in medical and deep tech companies in the western French Grand-Quest region. Founded in February 10, 2003, it seeks to invest in innovative seed-stage companies. It is approved by French stock market regulator AMF (Autorité des Marchés Financiers) and a member of French private equity and venture association AFIC (Association Française des Investisseurs pour la Croissance). The firm focuses on companies with high growth potential in MedTech, biotech, medical devices, robotics, energy equipment, analytics, and digital platforms. As of December 2019, the company has made 128 investments, with 58 portfolio and 38 exits.
A biotechnology company developing phage therapies for treating bacterial infections.